Feasibility of prehospital treatment with activated charcoal: Who could we treat, who should we treat?

Emergency Medicine Journal

Volumn 20, Issue 4, 2003, Pages 375-378

  Isbister, G K ^a   Dawson, A H ^a   Whyte, I M ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ALCOHOL; ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIHISTAMINIC AGENT; ARSENIC; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BORIC ACID; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CODEINE; COLCHICINE; FLECAINIDE; HYDROXYCHLOROQUINE; OPIATE; PARACETAMOL; QUININE; SEDATIVE AGENT; THEOPHYLLINE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; ZOLPIDEM; ZOPICLONE;

ADULT; AMBULANCE; ARTICLE; ASPIRATION PNEUMONIA; CLINICAL PROTOCOL; DATA BASE; DRUG COST; EMERGENCY WARD; FEASIBILITY STUDY; FEMALE; GLASGOW COMA SCALE; HEALTH CARE COST; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL CARE; HUMAN; INGESTION; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SEDATION; SELF POISONING; STANDARDIZATION;

EID: 0038637361     PISSN: 13510622     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.20.4.375     Document Type: Article

References (17)

1. Bond GR. The role of activated charcoal and gastric emptying in gastrointestinal decontamination: A state-of-the-art review. Ann Emerg Med 2002;39:273-86.
2. Pond SM, Lewis-Driver DJ, Williams GM, et al. Gastric emptying in acute overdose: A prospective randomised controlled trial. Med J Aust 1995;163:345-9.
3. Merigian KS, Woodard M, Hedges JR, et al. Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med 1990;8:479-83.
4. Albertson TE, Derlet RW, Foulke GE, et al. Superiority of activated charcoal alone compared with ipecac and activated charcoal in the treatment of acute toxic ingestions. Ann Emerg Med 1989;18:56-9.
5. Chyka PA, Seger D. Position statement: Single-dose activated charcoal. American Academy of Clinical Toxicology; European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 1997;35:721-41.
6. Karim A, Ivatts S, Dargan P, et al. How feasible is it to conform to the European guidelines on administration of activated charcoal within one hour of an overdose? Emerg Med J 2001;18:390-2.
7. Spiller HA, Rodgers GC Jr. Evaluation of administration of activated charcoal in the home. Pediatrics 2001;108:E100.
8. Thakore S, Murphy N. The potential role of prehospital administration of activated charcoal. Emerg Med J 2002;19:63-5.
9. Bond GR. Activated charcoal in the home: Helpful and important or simply a distraction? Pediatrics 2002;109:145-6.
10. Christophersen AB, Levin D, Hoegberg LC, et al. Activated charcoal alone or after gastric lavage: A simulated large paracetamol intoxication. Br J Clin Pharmacol 2002;53:312-17.
11. Menzies DG, Busuttil A, Prescott LF. Fatal pulmonary aspiration of oral activated charcoal. BMJ 1988;297:459-60.
12. Buckley NA, Whyte IM, Dawson AH, et al. Self-poisoning in Newcastle, 1987-1992. Med J Aust 1995;162:190-3.
13. Whyte IM, Buckley NA, Dawson AH. Data collection in clinical toxicology: Are there too many variables? J Toxicol Clin Toxicol 2002;40:223-30.
14. Buckley NA, Whyte IM, Dawson AH, et al. Preformatted admission charts for poisoning admissions facilitate clinical assesment and research. Ann Emerg Med 1999;34:476-82.
15. Buckley NA, Dawson AH, Whyte IM, et al. Relative toxicity of benzodiazepines in overdose. BMJ 1995;310:219-21.
16. Buckley NA, Whyte IM, O'Connell DL, et al. Activated charcoal reduces the need for N-acetylcysteine treatment after acetaminophen (paracetamol) overdose. J Toxicol Clin Toxicol 1999;37:752-7.
17. Isbister GK, Dawson AH, Whyte IM. Hydroxychloroquine overdose: A prospective case series. Am J Emerg Med 2002;20:377-8.